Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOKYO.L Regulatory News (OKYO)

  • There is currently no data for OKYO

Disposal

9 Jul 2010 11:44

For Immediate Release: 9 July 2010

EMERGING METALS LIMITED ("EML" or the "Company") Disposal

The Company is pleased to announce that it has entered into an agreement to dispose of its entire holding of 368,721 shares in Extract Resources Limited ("EXT Shares") to Nippon Uranium Resources (Australia) Proprietary Limited at a price of A$7.00 in cash per EXT Share. The gross proceeds of the sale will be A$2,581,047, approximately £1.48 million, which will be available for EML to apply in accordance with its investing policy approved by shareholders on 16 April. The sale is conditional on certain Australian regulatory approvals and completion is expected to be no later than 17 August 2010.

Extract Resources Limited ("EXT") is an ASX listed uranium exploration and development company with significant uranium assets in Namibia, namely the Husab uranium project comprising the Rossing South, Ida Dome and Hildenhof deposits and the EXT Shares represent approximately 0.15 per cent. of EXT's issued share capital.

ENQUIRIES:Emerging Metals Religare Capital Fox-Davies Capital GTH Communications Limited Markets Limited Daniel Fox-Davies Denham Eke Peter Toby Hall Trevelyan-Clark +44 (0) 20 7936 +44 (0) 1624 5200 Christian Pickel 639396 Emily Staples +44 (0) 20 3103 3900 +44 (0) 20 7444 0800

vendor
Date   Source Headline
14th Oct 20204:40 pmRNSSecond Price Monitoring Extn
14th Oct 20204:36 pmRNSPrice Monitoring Extension
14th Oct 20202:05 pmRNSSecond Price Monitoring Extn
14th Oct 20202:00 pmRNSPrice Monitoring Extension
13th Oct 20204:41 pmRNSSecond Price Monitoring Extn
13th Oct 20204:36 pmRNSPrice Monitoring Extension
13th Oct 20202:05 pmRNSSecond Price Monitoring Extn
13th Oct 20202:00 pmRNSPrice Monitoring Extension
13th Oct 202011:05 amRNSSecond Price Monitoring Extn
13th Oct 202011:00 amRNSPrice Monitoring Extension
9th Oct 20202:05 pmRNSSecond Price Monitoring Extn
9th Oct 20202:00 pmRNSPrice Monitoring Extension
9th Oct 202011:05 amRNSSecond Price Monitoring Extn
9th Oct 202011:00 amRNSPrice Monitoring Extension
9th Oct 20209:05 amRNSSecond Price Monitoring Extn
9th Oct 20209:00 amRNSPrice Monitoring Extension
25th Sep 20204:40 pmRNSSecond Price Monitoring Extn
25th Sep 20204:35 pmRNSPrice Monitoring Extension
25th Sep 202012:00 pmRNSUpload of Articles of Association to NSM
25th Sep 202012:00 pmRNSNotice of Results: AGM
9th Sep 20207:00 amRNSNotice of AGM
8th Sep 20209:17 amRNSIssue of convertible loan notes
21st Aug 20207:00 amRNSGrant of options – Director dealings
19th Aug 20207:00 amRNSDr. Napoleone Ferrara to Serve on the SAB
18th Aug 20202:06 pmRNSSecond Price Monitoring Extn
18th Aug 20202:01 pmRNSPrice Monitoring Extension
18th Aug 20207:00 amRNSOKYO: CLNs to raise £1.4m, intends to list: NASDAQ
17th Aug 20205:00 pmRNSFinal audited results for year ended 31 March 2020
17th Aug 20204:41 pmRNSSecond Price Monitoring Extn
17th Aug 20204:35 pmRNSPrice Monitoring Extension
7th Aug 20207:00 amRNSDr James Khodabakhsh MD named Chairman of the SAB
6th Aug 20207:00 amRNSHolding(s) in Company
3rd Aug 20204:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20204:35 pmRNSPrice Monitoring Extension
3rd Aug 20202:05 pmRNSSecond Price Monitoring Extn
3rd Aug 20202:00 pmRNSPrice Monitoring Extension
3rd Aug 202011:05 amRNSSecond Price Monitoring Extn
3rd Aug 202011:00 amRNSPrice Monitoring Extension
3rd Aug 20209:05 amRNSSecond Price Monitoring Extn
3rd Aug 20209:00 amRNSPrice Monitoring Extension
28th Jul 20208:51 amRNSIssue of convertible loan notes
10th Jun 20204:42 pmRNSDirectorate Change
5th Jun 202010:32 amRNSNotification of Major Holdings
3rd Jun 202011:09 amRNSAppointment of Broker
29th May 20206:09 pmRNSCLN Issue
28th May 20206:20 pmRNSPlacing update
27th May 20202:13 pmRNSHolding(s) in Company
27th Apr 202010:45 amRNSHolding(s) in Company
30th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20207:00 amRNSUpdate on Placing to raise £560,000

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.